Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

129.63
Delayed Data
As of Aug 26
 +0.46 / +0.36%
Today’s Change
110.56
Today|||52-Week Range
193.45
-32.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Operating ActivitiesNet Income / Starting Line-183.8M66.6M92.2M114.9M
 
 
 
 
 
Depreciation49.7M87.4M96.8M97.8M
 
 
 
 
 
Total Other Cash Flow171.1M108.5M40.6M59.2M
 
 
 
 
 
Funds From Operations426.5M272.0M258.9M318.7M
 
 
 
 
 
Funds From/For Other Operating Expenses203.4M81.2M90.9M74.8M
 
 
 
 
 
Net Cash Flow - Operating Activities223.1M190.9M168.0M243.9M
 
 
 
 
 
 
InvestingIncrease In Investments-193.6M-149.9M-211.0M-288.6M
 
 
 
 
 
Decrease In Investments70.4M68.4M269.5M24.9M
 
 
 
 
 
Capital Expenditures-76.1M-80.1M-64.2M-66.8M
 
 
 
 
 
Net Assets From Acquisitions -39.0K0.000.000.00
 
 
Other Investing - Uses0.000.000.00-52.0K
 
 
Other Investing - Sources4.1M-5.0K82.0K-82.0K
 
 
 
 
 
Net Cash Flow Investing-195.2M-161.6M-5.7M-330.7M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.00-43.8M-175.0M0.00
 
 
 
Net Proceeds Stock Sale19.1M27.1M9.4M10.7M
 
 
 
 
 
Common Preferred Redeemed-91.8M-152.3M-296.5M-34.1M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing15.2M0.000.000.00
 
 
Other Uses - Financing127.6M12.3M4.1M681.0K
 
 
 
 
 
Net Cash Flow - Financing-185.0M-181.3M-466.3M-24.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.7M-1.1M4.0M-1.8M
 
 
 
 
 
 
Net Change In Cash-157.1M-152.0M-303.9M-110.8M